New Tumor Therapy Approach To Reduce Costs and Side Effects while Increasing Accessibility; Carl Zeiss Foundation Funding KIT and DKFZ Joint Project

Scientists are working hard on ways to minimize radiation therapy’s side effects on patients. A joint project of the Karlsruhe Institute of Technology (KIT) and the German Cancer Research Center (DKFZ) aims to take a major step toward this goal. With its innovative technology, tumors could be irradiated in the body with a tiny electron accelerator while causing minimal damage to healthy tissue. The project, called “ultracompact electron accelerators for internal radiotherapy” (UCART), has been added to the Carl Zeiss Foundation’s Wildcard program as an “unconventional research project”.

For more details read the press release.